Howard Hughes (HHH) director awarded 2,464 restricted shares at $0
Howard Hughes Holdings Inc. (HHH) reported an insider equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Howard Hughes Holdings Inc. (HHH) reported an insider equity award. Director Thom Lachman received 2,464 restricted shares of common stock on 10/24/2025 at a $0 grant price under the company’s 2025 Equity Incentive Plan.
The award vests on the earlier of one year from grant or the day of the company’s 2026 annual meeting of stockholders, but not less than 50 weeks. Following this grant, the filing lists 2,464 shares beneficially owned, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common stock, $0.01 par value | 2,464 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan. The shares vest on the earlier of one year from the date of grant or the day of the Issuer's 2026 annual meeting of stockholders (but not less than 50 weeks).
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Howard Hughes (HHH) disclose in this Form 4?
What is the vesting schedule for the HHH director’s restricted stock?
What plan governed the restricted stock grant at HHH?
What is the reporting person’s relationship to Howard Hughes (HHH)?
AI-generated analysis. How Rhea-AI works. Not financial advice.